Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

Completed · Phase 2

Conditions studied: Myocardial Infarction

In brief

The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.

Key facts

Study ID

NCT00310544

Run by

Bayer

People needed

73

Starts

2006-03-01

Expected to finish

2006-09-01

Last updated by the study team

2014-12-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 8 weeks post-documented myocardial infarction (heart attack)

You may not qualify if…

• History of radiation therapy to the chest
• Clinically unstable
• Any contraindication for MRI

Where it is running

• Study site — San Diego, California, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Portland, Oregon, United States
• Study site — Hershey, Pennsylvania, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Buenos Aires, Buenos Aires, Argentina

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.